Mexico digestive remedies market: Mx$6.1 billion industry in 2012

Press Release   •   Jul 17, 2013 14:57 BST

Pisa Laboratorios led the mexico digestive remedies market with an 18% value share in 2012, thanks to the successful marketing campaign for Electrolit (diarrhoeal remedies). Second was Genomma Lab Internacional with a 9% value share, made up by its brands Genoprazol (proton pump inhibitors), QG5 (antacids) and Suerox (diarrhoeal remedies).

Paediatric digestive remedies is quite underdeveloped in Mexico, as many regular digestive products are used in lower doses to treat children's ailments. Diarrhoeal remedies is the most important category, accounting for 92% of all paediatric digestive remedies. Oral serums are amongst the most successful in this category, with brands such as Pedialyte (Abbott Laboratorios), Electrolit (Pisa Laboratorios) and Suerox (Genomma Lab).

Digestive remedies is expected to increase by a CAGR of 3% in constant value terms in the forecast period, mainly driven by the growth of antacids, which is expected to increase by a CAGR of 6%. This is due to the nature of Mexican cuisine, which is spicy and fatty, and tends to cause digestive problems.

For more information on the Mexico digestive remedies market, please click here: Mexico digestive remedies market issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.